🇧🇷 Selg1 in Brazil

Selg1 (CRIZANLIZUMAB) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Selg1 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in Brazil

Frequently asked questions

Is Selg1 approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Selg1 in Brazil?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.